Protalix BioTherapeutics (PLX) Other Working Capital Changes (2010 - 2024)

Protalix BioTherapeutics' Other Working Capital Changes history runs 15 years deep, the most recent figure standing at $252062.0 for Q4 2024.

• In Q4 2024, Other Working Capital Changes changed N/A year-over-year to $252062.0; the TTM figure through Dec 2024 stood at $252062.0 (up 101.91% YoY), while the FY2024 annual figure was $252062.0, up 101.91% from the prior year.
• Other Working Capital Changes was $252062.0 for Q4 2024 at Protalix BioTherapeutics, down from $1.7 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $12.3 million in Q2 2021 to a low of -$25.7 million in Q4 2020.
• Historically, Other Working Capital Changes has averaged -$2.1 million across 5 years, with a median of -$192500.0 in 2020.
• The sharpest annual moves came in 2020 and 2021: Other Working Capital Changes sank 14850.0% in 2020, then soared 14394.19% in 2021.
• A 5-year view of Other Working Capital Changes shows it stood at -$25.7 million in 2020, then soared by 45.63% to -$14.0 million in 2021, then surged by 88.46% to -$1.6 million in 2022, then sank by 630.03% to -$11.8 million in 2023, then soared by 102.14% to $252062.0 in 2024.
• The last three Other Working Capital Changes figures came in at $252062.0 (Q4 2024), $1.7 million (Q2 2024), and $11.0 million (Q1 2024), per Business Quant data.